Published in Neth J Med on December 01, 1998
Recombinant activated clotting factor VII (rFVIIa) in the treatment of surgical and spontaneous bleeding episodes in hemophilic patients. Vasc Health Risk Manag (2006) 0.75
Lipid rafts reconstituted in model membranes. Biophys J (2001) 9.19
Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost (2001) 6.16
Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med (1999) 4.85
Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. Proc Natl Acad Sci U S A (1998) 4.72
Partitioning of Thy-1, GM1, and cross-linked phospholipid analogs into lipid rafts reconstituted in supported model membrane monolayers. Proc Natl Acad Sci U S A (2001) 3.12
Two-photon fluorescence microscopy of laurdan generalized polarization domains in model and natural membranes. Biophys J (1997) 2.56
Oral anticoagulation self-management and management by a specialist anticoagulation clinic: a randomised cross-over comparison. Lancet (2000) 2.49
[Co-morbidity in acutely hospitalised older patients as a risk factor for death in hospital or within 3 months after discharge]. Ned Tijdschr Geneeskd (2007) 2.17
Systematic review of survival after acute mesenteric ischaemia according to disease aetiology. Br J Surg (2004) 2.14
Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation. J Thromb Haemost (2004) 2.09
Management of cancer-associated disseminated intravascular coagulation: guidance from the SSC of the ISTH. J Thromb Haemost (2015) 2.02
Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J Exp Med (1994) 1.64
Regulation of interleukin 10 release by tumor necrosis factor in humans and chimpanzees. J Exp Med (1994) 1.63
Local activation of coagulation and inhibition of fibrinolysis in the lung during ventilator associated pneumonia. Thorax (2004) 1.63
Human liver sinusoidal endothelial cells but not hepatocytes contain factor VIII. J Thromb Haemost (2014) 1.61
Factor VIII gene inversions in severe hemophilia A: results of an international consortium study. Blood (1995) 1.59
Occult polymicrobial endocarditis with Haemophilus parainfluenzae in intravenous drug abusers. Am J Med (1989) 1.57
Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders. J Thromb Haemost (2012) 1.56
Short-term and long-term mortality in very elderly patients admitted to an intensive care unit. Intensive Care Med (2006) 1.55
Quality of life and metabolic control in patients with diabetes mellitus type 1 treated by continuous subcutaneous insulin infusion or multiple daily insulin injections. Neth J Med (2004) 1.52
Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines. J Thromb Haemost (2013) 1.50
Interleukin-6 stimulates coagulation, not fibrinolysis, in humans. Thromb Haemost (1996) 1.47
Systemic inflammation as a risk factor for atherothrombosis. Rheumatology (Oxford) (2007) 1.43
Risk of pocket hematoma in patients on chronic anticoagulation with warfarin undergoing electrophysiological device implantation: a comparison of different peri-operative management strategies. Eur Rev Med Pharmacol Sci (2015) 1.42
Absence of Pneumocystis jiroveci pneumonia in liver transplantation recipients receiving short-term (3-month) prophylaxis. Transpl Infect Dis (2008) 1.41
[Diagnostic and pharmaco-therapeutic options in acute severe blood loss]. Ned Tijdschr Geneeskd (2004) 1.39
Additive effect of dDAVP and standard heparin in increasing plasma t-PA. Thromb Haemost (1989) 1.39
[Anticoagulant treatment of patients with atrial fibrillations: dependent on age and other risk factors for thromboembolism]. Ned Tijdschr Geneeskd (2002) 1.39
[A patient with repeated, life-threatening gastro-intestinal haemorrhages treated by means of medication, open surgery, endoscopic surgery, intervention radiology and conservative methods]. Ned Tijdschr Geneeskd (2007) 1.39
The compliance with antidepressants in general practice. J Psychopharmacol (1994) 1.39
[Reasons why patients do or do not participate in clinical trials; a systemic review of the literature]. Ned Tijdschr Geneeskd (2004) 1.38
Development of new photon-counting detectors for single-molecule fluorescence microscopy. Philos Trans R Soc Lond B Biol Sci (2012) 1.32
Parathyroid hormone action on phosphate transporter mRNA and protein in rat renal proximal tubules. Am J Physiol (1995) 1.30
Differential effects of anti-tumor necrosis factor monoclonal antibodies on systemic inflammatory responses in experimental endotoxemia in chimpanzees. Blood (1994) 1.28
Analysis of coagulation cascade and endothelial cell activation during inhibition of vascular endothelial growth factor/vascular endothelial growth factor receptor pathway in cancer patients. Arterioscler Thromb Vasc Biol (2002) 1.26
Effects of different plasma substitutes on blood coagulation: a comparative review. Crit Care Med (2001) 1.26
Monoclonal antibodies specific for canine CD4 and CD8 define functional T-lymphocyte subsets and high-density expression of CD4 by canine neutrophils. Tissue Antigens (1992) 1.22
Mechanism and kinetics of factor VIII inactivation: study with an IgG4 monoclonal antibody derived from a hemophilia A patient with inhibitor. Blood (1998) 1.22
Renal brush border membrane Na/Pi-cotransport: molecular aspects in PTH-dependent and dietary regulation. Kidney Int (1996) 1.22
Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI. In vivo evidence for a role of factor XI as an anti-fibrinolytic factor. J Clin Invest (1998) 1.21
The pathophysiology of disseminated intravascular coagulation. Thromb Haemost (1999) 1.14
Effects of vitamin D-induced chronic hypercalcemia on rat renal cortical plasma membranes and mitochondria. Am J Physiol (1987) 1.14
Replicon clusters may form structurally stable complexes of chromatin and chromosomes. J Cell Sci (1994) 1.13
Fluorouracil selectively spares acute myeloid leukemia cells with long-term growth abilities in immunodeficient mice and in culture. Blood (1996) 1.13
A prospective 10 year follow up study of patients with neurofibromatosis type 1. Arch Dis Child (1998) 1.13
Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction: a systematic review. Circulation (2001) 1.12
Tubulin: an integral protein of mammalian synaptic vesicle membranes. J Neurochem (1980) 1.11
Deletions spanning the neurofibromatosis type 1 gene: implications for genotype-phenotype correlations in neurofibromatosis type 1? Hum Mutat (1997) 1.11
Factor VIII deficiency does not protect against atherosclerosis. J Thromb Haemost (2012) 1.11
Fibrinolytic response to tumor necrosis factor in healthy subjects. J Exp Med (1991) 1.11
Advanced glycation end products: a Nephrologist's perspective. Am J Kidney Dis (2000) 1.10
Regulatory role of cytokines in disseminated intravascular coagulation. Semin Thromb Hemost (2001) 1.09
Disturbed alveolar fibrin turnover during pneumonia is restricted to the site of infection. Eur Respir J (2004) 1.08
Serum enzyme inhibitor concentrations in the respiratory distress syndrome. Am Rev Respir Dis (1970) 1.08
Estrogen downregulates the proximal tubule type IIa sodium phosphate cotransporter causing phosphate wasting and hypophosphatemia. Kidney Int (2008) 1.07
Clonal expansion of Staphylococcus epidermidis strains causing Hickman catheter-related infections in a hemato-oncologic department. J Clin Microbiol (1998) 1.06
MR imaging of intra-osseous hemophilic pseudotumor: case report and review ofthe literature. JBR-BTR (2005) 1.06
Interleukin-10 inhibits activation of coagulation and fibrinolysis during human endotoxemia. Blood (1997) 1.06
Interactions of the growth-related, type IIc renal sodium/phosphate cotransporter with PDZ proteins. Kidney Int (2007) 1.06
Hepatitis C virus-RNAs in plasma and in peripheral blood mononuclear cells of hemophiliacs with chronic hepatitis C: evidence for viral replication in peripheral blood mononuclear cells. J Med Virol (1994) 1.05
The activation of factor X and prothrombin by recombinant factor VIIa in vivo is mediated by tissue factor. J Clin Invest (1993) 1.05
Release of soluble receptors for tumor necrosis factor in clinical sepsis and experimental endotoxemia. J Infect Dis (1993) 1.05
Nucleic acid testing (NAT) of organ donors: is the 'best' test the right test? A consensus conference report. Am J Transplant (2010) 1.05
Coagulation factor XI as a novel target for antithrombotic treatment. J Thromb Haemost (2010) 1.04
Value of different modalities of granulocyte-macrophage colony-stimulating factor applied during or after induction therapy of acute myeloid leukemia. J Clin Oncol (1997) 1.04
Osteonecrosis in HIV: a case-control study. J Acquir Immune Defic Syndr (2000) 1.04
Maturational effects of glucocorticoids on neonatal brush-border membrane phosphate transport. Pediatr Res (1994) 1.03
Role of microtubules in the rapid regulation of renal phosphate transport in response to acute alterations in dietary phosphate content. J Clin Invest (1997) 1.03
Inhibitor treatment in haemophilias A and B: summary statement for the 2006 international consensus conference. Haemophilia (2006) 1.03
Potential role of platelets in endothelial damage observed during treatment with cisplatin, gemcitabine, and the angiogenesis inhibitor SU5416. J Clin Oncol (2003) 1.02
Suppression of experimental autoimmune neuritis by ABR-215062 is associated with altered Th1/Th2 balance and inhibited migration of inflammatory cells into the peripheral nerve tissue. Neuropharmacology (2002) 1.02
Review article: blood platelet number and function in chronic liver disease and cirrhosis. Aliment Pharmacol Ther (2008) 1.01
Tumor necrosis factor-alpha inhibition protects against endotoxin-induced endothelial glycocalyx perturbation. Atherosclerosis (2008) 1.01
Impaired haemostasis by intravenous administration of a gelatin-based plasma expander in human subjects. Thromb Haemost (1998) 1.01
Coagulation abnormalities in type 1 Gaucher disease are due to low-grade activation and can be partly restored by enzyme supplementation therapy. Br J Haematol (1997) 1.00
Functional roles of the plant alpha-like and gamma-like DNA polymerases. FEBS Lett (1981) 1.00
A human antibody directed to the factor VIII C1 domain inhibits factor VIII cofactor activity and binding to von Willebrand factor. Blood (2000) 1.00
Vagus nerve stimulation inhibits activation of coagulation and fibrinolysis during endotoxemia in rats. J Thromb Haemost (2006) 1.00
Application of the voluntary step execution test to identify elderly fallers. Age Ageing (2007) 1.00
Epitope specificity of 30 monoclonal antibodies against cytokeratin antigens: the ISOBM TD5-1 Workshop. Tumour Biol (1998) 0.99
Rapid downregulation of rat renal Na/P(i) cotransporter in response to parathyroid hormone involves microtubule rearrangement. J Clin Invest (1999) 0.99
Quantitative differentiation between healthy and disordered brain matter in patients with neurofibromatosis type I using diffusion tensor imaging. AJNR Am J Neuroradiol (2008) 0.99
Acute hepatitis A in patients with haemophilia A. Lancet (1993) 0.99
Interleukin-12 induces sustained activation of multiple host inflammatory mediator systems in chimpanzees. J Infect Dis (1999) 0.99
A novel cause of mild/moderate hemophilia A: mutations scattered in the factor VIII C1 domain reduce factor VIII binding to von Willebrand factor. Blood (2000) 0.98
Plasminogen activator and plasminogen activator inhibitor I release during experimental endotoxaemia in chimpanzees: effect of interventions in the cytokine and coagulation cascades. Clin Sci (Lond) (1995) 0.97
Natural anticoagulants limit lipopolysaccharide-induced pulmonary coagulation but not inflammation. Eur Respir J (2007) 0.97
Outcome and predictive factors of mortality in hospitalized HIV-patients in Burkina Faso. Infection (2009) 0.97
Recombinant human tissue factor pathway inhibitor exerts anticoagulant, anti-inflammatory and antimicrobial effects in murine pneumococcal pneumonia. J Thromb Haemost (2011) 0.97
Mouse models of focal arterial and venous thrombosis. Basic Res Cardiol (2000) 0.97
Effect of a recombinant dimeric tumor necrosis factor receptor on inflammatory responses to intravenous endotoxin in normal humans. Blood (1997) 0.97
Immunodominant glycoprotein 41 epitope identified by seroreactivity in HIV type 1-infected individuals. AIDS Res Hum Retroviruses (1996) 0.96
Role of thyroid hormone in regulation of renal phosphate transport in young and aged rats. Endocrinology (1999) 0.96
Mechanism of concentrating defect in hypercalcemia. Role of polydipsia and prostaglandins. Kidney Int (1983) 0.96
Pentoxifylline attenuates neutrophil activation in experimental endotoxemia in chimpanzees. J Immunol (1993) 0.95
Two neutralizing anti-V3 monoclonal antibodies act by affecting different functions of human immunodeficiency virus type 1. J Gen Virol (1996) 0.94
Beneficial effect of treatment with a monoclonal anti-tumor necrosis factor-alpha antibody on markers of coagulation and fibrinolysis in patients with active Crohn's disease. Haemostasis (1998) 0.94
Renal Na/H exchanger NHE-3 and Na-PO4 cotransporter NaPi-2 protein expression in glucocorticoid excess and deficient states. J Am Soc Nephrol (1998) 0.94